These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 1927543)

  • 21. Increased synthesis of systemic prostacyclin in cirrhotic patients.
    Guarner F; Guarner C; Prieto J; Colina I; Quiroga J; Casas J; Freixa R; Rosello J; Gelpi E; Balanzo J
    Gastroenterology; 1986 Mar; 90(3):687-94. PubMed ID: 3510938
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of sulindac and naproxen on prostaglandin excretion in patients with impaired renal function and rheumatoid arthritis.
    Eriksson LO; Sturfelt G; Thysell H; Wollheim FA
    Am J Med; 1990 Sep; 89(3):313-21. PubMed ID: 2203262
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vascular sensitivity to prostaglandin I2 and urinary excretion of 6-keto-prostaglandin F1 alpha in conscious dogs.
    Jones RL; Watson ML
    Clin Sci (Lond); 1986 Nov; 71(5):527-32. PubMed ID: 3533394
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prostacyclin: its pathogenic role in essential hypertension and the class effect of ACE inhibitors on prostaglandin metabolism.
    Rodríguez-García JL; Villa E; Serrano M; Gallardo J; García-Robles R
    Blood Press; 1999; 8(5-6):279-84. PubMed ID: 10803488
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Urinary 6-keto-prostaglandin F1 alpha (6-keto-PGF1 alpha) excretion and its relation to plasma renin activity in hyperthyroidism.
    Földes J; de Chatel R; Bános C; Tarján G
    Horm Metab Res; 1987 Dec; 19(12):667-8. PubMed ID: 3326813
    [No Abstract]   [Full Text] [Related]  

  • 26. Urinary excretion of 6-keto prostaglandin F1 alpha in pre-eclampsia.
    Yamaguchi M; Mori N
    Arch Gynecol Obstet; 1988; 244(1):7-13. PubMed ID: 3240007
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Abnormal response of urinary eicosanoid system to norepinephrine infusion in patients with essential hypertension.
    Uehara Y; Ishimitsu T; Kawabata Y; Matsuoka H; Ishii M; Sugimoto T
    Prostaglandins Leukot Essent Fatty Acids; 1992 Jun; 46(2):99-104. PubMed ID: 1502257
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolism of prostacyclin and 6-keto-prostaglandin F1 alpha in man.
    Rosenkranz B; Fischer C; Weimer KE; Frölich JC
    J Biol Chem; 1980 Nov; 255(21):10194-8. PubMed ID: 7000774
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of spironolactone on renal prostaglandin excretion in patients with liver cirrhosis and ascites.
    Medina JF; Prieto J; Guarner F; Quiroga J; Milazzo A
    J Hepatol; 1986; 3(2):206-11. PubMed ID: 3466948
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The contribution of PGI2 to the effects of captopril in conscious dogs in differing states of sodium balance.
    Watson ML; Jones RL
    Clin Sci (Lond); 1986 Nov; 71(5):533-8. PubMed ID: 3533395
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Facile method for preparation of 2,3-dinor-6-keto PGF1 alpha, the major urinary metabolite of prostacyclin.
    Balazy M; Brass EP; Gerber JG; Nies AS
    Prostaglandins; 1988 Oct; 36(4):421-30. PubMed ID: 3070630
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of prostacyclin infusion on blood pressure and plasma renin activity in patients with essential hypertension.
    Kato T; Yoneda S; Koketsu M; Fujinami T
    Angiology; 1992 Feb; 43(2):110-20. PubMed ID: 1536471
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in urinary 6-keto-prostaglandin F1 alpha excretion during pregnancy and labor.
    Noort WA; de Zwart FA; Keirse MJ
    Prostaglandins; 1988 Apr; 35(4):573-82. PubMed ID: 3247472
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vaginal and abdominal delivery increases maternal urinary 6-keto-prostaglandin F1 alpha excretion.
    Ylikorkala O; Paatero H; Suhonen L; Viinikka L
    Br J Obstet Gynaecol; 1986 Sep; 93(9):950-4. PubMed ID: 3768289
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Simultaneous measurement of two major prostacyclin metabolites in urine.
    Zureick S; Nadler J; Yamamoto J; Horton R
    Clin Chem; 1990 Nov; 36(11):1978-80. PubMed ID: 2242582
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Urinary excretion of prostacyclin metabolites in infants born after maternal preeclampsia or with birth asphyxia.
    Ruth V; Ylikorkala O; Viinikka L; Raivio KO
    Biol Neonate; 1989; 56(2):83-9. PubMed ID: 2506939
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Excretion of 6-keto-PGF1 alpha and PGE2 in rats with hereditary hypothalamic diabetes insipidus.
    Güllner HG; Graf AK; Mitchell MD
    Prostaglandins Leukot Med; 1983 Jan; 10(1):95-9. PubMed ID: 6572406
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of age, sex and potassium excretion on urinary prostaglandins in children.
    Barden A; Beilin LJ; Vandongen R; Rouse I
    Clin Sci (Lond); 1985 May; 68(5):601-4. PubMed ID: 3856502
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increases in urinary kallikrein activity and prostanoid synthesis after dietary potassium supplementation.
    Barden A; Vandongen R; Beilin LJ
    Clin Exp Pharmacol Physiol; 1987 Jul; 14(7):565-72. PubMed ID: 3436102
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effects of continued sodium chloride loading on urinary kallikrein, aldosterone and 6-keto-PGF1 alpha].
    Igari T; Uehara Y; Ishii M
    Nihon Jinzo Gakkai Shi; 1983 Jul; 25(7):920-2. PubMed ID: 6559220
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.